Mylan Inks $96.5M Pay-For-Delay Deal With Cephalon Buyers
Mylan Pharmaceuticals Inc. has agreed to pay $96.5 million to settle with direct purchasers in pay-for-delay litigation over Cephalon's narcolepsy drug Provigil, according to a court filing in Pennsylvania federal court....To view the full article, register now.
Already a subscriber? Click here to view full article